LETTER TO WILLIAM H. WEBSTER FROM DAVID PICKENS

• Document Type: CREST
• Collection: General CIA Records
• Document Number (FOIA) /ESDN (CREST): CIA-RDP90G01353R000200190003-1
• Release Decision: RIPPUB
• Original Classification: K
• Document Page Count: 14
• Document Creation Date: December 27, 2016
• Document Release Date: November 8, 2012
• Sequence Number: 3
• Publication Date: September 29, 1988
• Content Type: LETTER

Declassified in Part - Sanitized Copy Approved for Release
2012/11/08: CIA-RDP90G01353R000200190003-1
THE FOLLOWING DOCUMENTS
ARE ATTACHED:
(Please do not remove)
Declassified in Part - Sanitized Copy Approved for Release
2012/11/08: CIA-RDP90G01353R000200190003-1
 Declassified in Part - Sanitized Copy Approved for Release
2012/11/08: CIA-RDP90GO1353R000200190003-1
ROUTING SLIP
ACTION
INFO
DATE
INITIAL
1
2
DDCI
3
EXDIR
4
D/ICS
5
DDI
6
DDA
7
DDO
8
DDS&T
9
Chm/NIC
10
GC
11
IG
12
Compt
13
D/OCA
14
D/PAO
15
D/PERS
16
D/Ex Staff
17
18
19
20
21
22
STAT
30 Sept '88
Declassified in Part - Sanitized Copy Approved for Release
2012/11/08: CIA-RDP90GO1353R000200190003-1
 Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90GO1353R000200190003-1
ER 88-3676X
NATIONAL DRUG POLICY BOARD
Washington, D.C. 20530
September 29, 1988
The next meeting of the National Drug Policy Board is set
for October 3, 1988, at 1:00 p.m., in the Roosevelt Room, The
White House. The President is scheduled to attend this meeting.
This being the Chairman's first Policy Board meeting, we would
very much appreciate your attendance. Enclosed are the
agenda/fact sheet and the summary of minutes for the
July 27, 1988 meeting.
If you or your staff have any questions regarding the
meeting, please do not hesitate to contact me (633-3435).
The Honorable William H. Webster
Director
Central Intelligence Agency
Washington, D.C. 20505
cc: The Honorable William R. Kotapish
 Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90GO1353R000200190003-1
4 Y
NATIONAL DRUG POLICY BOARD
Washington, D.C. 20530
AGENDA/FACT SHEET
National Drug Policy Board Meeting
Monday, October 3, 1988
1:00 P.M., Roosevelt Room
The White House
I. Introductory Remarks
II. 1988 Omnibus Drug Legislation
Alan Kranowitz, Assistant to the President for Legislative
Affairs will review the current status of the 1988 Drug
Bill.
Salvatore R. Martoche, Vice Chairman of the Drug Enforcement
Coordinating Group and Dr. Ian MacDonald, Chairman of the
Drug Abuse Prevention and Health Coordinating Group, will
comment on the impact that the drug legislation may have
regarding specific supply and demand strategies.
III. National Drug Policy Board Strategy Implementation Plans
Mr. Martoche and Dr. MacDonald will outline the process to
audit the Strategy Implementation Plans of the Policy Board.
As indicated to the Congress, the Policy Board Lead Agencies
will review the Implementation Plans. The National Drug
Policy Board Staff assessment of the drug strategies have
begun with the submission of the Lead Agency's report.
IV. FY 1990, Drug Budget Review
Office of Management and Budget Director, Jim Miller, will
outline the projections for the FY 1990 drug budgets.
V. International Drug Control Efforts
Secretary of State George Shultz recently traveled to South
America.
Assistant Secretary for Inter-American Affairs, Elliott
Abrams will provide background on the South American trip
and the current situation.
Assistant Secretary for International Narcotics Matters Ann
Wrobleski will discuss results of the experts' group
meeting which was held as a follow-up to the Seven
Industrial Nations,Toronto Summit.
Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90GO1353R000200190003-1
 Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90G01353R000200190003-1
VI. Drug-Free America Week
Dr. Otis Bowen, Vice Chairman and Secretary of Health and
Human Services will review the schedule of activities
highlighting Drug-Free America, Week scheduled for October
24 - 30, 1988.
VII. Closing Remarks
Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90G01353R000200190003-1
 Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90G01353R000200190003-1
NATIONAL DRUG POLICY BOARD
Summary of Meeting
July 27, 1988
I. Introductory Remarks. The Chairman convened the meeting at
3:00 P.M. Dr. Bowen, the Vice Chairman, made an opening
statement thanking Mr. Meese for his extensive work on the
front lines of the war on drugs, for his loyalty to the
President and his contributions to the Administration's
successes.
II. Legislative Initiative Update. Mr. Keating summarized the
progress achieved. He and Dr. Macdonald presented the
NDPB's concept package on the Hill. They met with Alan
Kronowitz, who agreed to lead the overall legislative effort
with Mr. Keating and Dr. Macdonald as his principal resource
people, along with other NDPB representatives. This working
group will divide in five sub-groups and designate
departments to lead development of specific proposals. The
sub-groups will further subdivide according to issues.
III. DOD Authorization Bill. Secretary Carlucci addressed the
DOD Mission Statement and stated that DOD is capable of
doing drug detection and monitoring, however there are
resource problems. He also acknowledged that this will be a
large task which will probably trigger some turf sensitivi-
ty. Thus, he explained that DOD has not sought this mission
and that DOD will work fully with Customs and the Coast
Guard in the development of implementation plans.
Mr. Keating remarked that the DOD Mission Statement was
agreed to by all parties, and that Customs and the Coast
Guard had participated in the drafting of the statement.
The Enforcement Coordinating Group has requested that
Customs and the Coast Guard continue to lead the overall
interdiction policy.
Ms. Dawson (Transportation) asked that the Board devise a
mechanism through which problems (if any should arise) can
be solved. The Chairman proposed that the Coordinating
Groups be that mechanism, but if the problems cannot be
solved at that level the Board will meet quickly to resolve
any disputes. The Board approved this proposal.
IV. Public Health Service Proposal. Secretary Bowen proposed
that Federal expertise be used to assist in the development
of innovative drug treatment programs. .Specifically the
Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90G01353R000200190003-1
 Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90G01353R000200190003-1
proposal involves the use of underutilized medical
facilities or those targeted for closure on military bases,
as drug treatment centers. These centers would be operated
under State/local control, with HHS (Public Health Service)
technical assistance. Secretary Carlucci stated that DOD
would be happy to cooperate in this matter. The Chairman and
the Board gave their support to this proposal which HHS will
begin to implement with DOD.
V. Office of Workplace Initiatives. Dr. Bowen explained that
the office of Workplace Initiatives oversees the Federal
government's drug-free workplace program. He stated that
the Office is seriously in need of funding. It needs
approximately $ 1 million to cover the operating costs for
the rest of this year and an additional $2.8 million to be
made available for 1989. He proposed that these costs be
distributed among the various agencies based on their
participation in the program. The Board unanimously
approved this proposal and directed that it be submitted to
OMB for clarification of each agency's share of the costs.
VI. Drug-Free Workplace. Secretary Verity reported on the
Department of Commerce's progress in its meetings with the
private sector regarding drug-free workplaces. Mr. Verity
was particularly impressed with Phillips Industries, which
established a policy of zero tolerance in its plants.
Commerce will begin a private/public partnership which will
result in a program involving random drug testing, testing
of all new employees and the promotion of employees
generated interest in a drug-free workplace. The Chairman
asked the Drug Prevention and Health Coordinating Group to
coordinate this effort with other on-going projects.
VII. President's Commission on AIDS Report. Dr. Macdonald
reported that out .of the report's 597 recommendations,
chapter eight has 51 drug specific recommendations. He
observed that most of these issues have already been
addressed by the NDPB. On a separate subject Dr. Macdonald
informed the Board that five or six States have not applied
for drug treatment funds for FY88.
VIII.Drug Eradication Issues. Mr. Keating informed the Board
that President Garcia of Peru intends to start drug
eradication, and the U.S. can help by providing herbicides.
However, at the present time the company which produces the
herbicide "Spike," will not sell it to the government. Mr.
Keating noted that the Enforcement Coordinating Group has
approved a resolution condemning the company, and asks the
Chairman to invite the CEOs of several chemical
manufacturing companies to come to Washington to discuss
this issue. Other options proposed by the Coordinating
Group included the purchase of the patent for the herbicide,
Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90G01353R000200190003-1
 Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90GO1353R000200190003-1
or if that is not possible the boycott of these companies'
products by all governmental agencies.
Ms. Wrobleski informed the Board that State has been in
contact with the company and that "Spike" is only one of the
three chemicals being tested for use in Peru. Peru has not
decided yet which chemical it will use.
Dr. Bowen explained that one chemical company might be
willing to sell the formula to the government or to sell
the chemicals to the government if it is willing to take
responsibility for liability.
The Chairman summarized that testing of the chemicals will
go forward, the companies should be encouraged to cooperate,
and if talks with the leaders of these companies would be
productive the Chairman will engage in such talks. He asked
Mr. Keating to review the options and to make any necessary
recommendations to the Policy Board.
The meeting concluded at 4:10 P.M.
Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90GO1353R000200190003-1
 Declassified in Part - Sanitized Copy Approved for Release
2012/11/08: CIA-RDP90GO1353R000200190003-1
EXECUTIVE SECRETARIAT
ROUTING SLIP
ACTION
INFO
DATE
INITIAL
1
DCI
X
2
DDCI
x
3
EXDIR
4
D/ICS
5
DDI
x
6
DDA
7
DDO
8
DDS&T
9
Chm/NIC
10
GC
11
IG
12
Compt
13
D/OCA
14
D/PAO
15
D/PERS
16
D/Ex Staff
17
NIO/CN
X
18
DCI
x
19
20
21
22
Remarks
The DCI plans to attend, schedule permitting.
The_DDI will attend if DCI cannot '7he Board
secretary concurs in this 'arrangement.
STAT
Executive Secretary
20.JUL 88
Dais
. AA_27 0")
Declassified in Part - Sanitized Copy Approved for Release
2012/11/08: CIA-RDP90GO1353R000200190003-1
 ? 4
Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90GO1353R000200190003-1
NATIONAL DRUG POLICY BOARD
Washington, D.C. 20530
July 19, 1988
ExecutiveRegistry
The next meeting of the National Drug Policy Board is set
for July 27, 1988, for principals only, 3:00 p.m., in the
Roosevelt Room, The White House. This meeting will immediately
follow the Domestic Policy Council meeting. As this will be the
Chairman's last Policy Board meeting, we would very much
appreciate your attendance. Enclosed are the draft agenda and
the summary of minutes for the June 23, 1988 meeting.
If you have any questions regarding the meeting, please do
not hesitate to contact me (633-3435).
Sincerely,
David Pickens
Exec ive Director
The Honorable William H. Webster
Director
Central Intelligence Agency
Washington, D.C.. 20505
cc: The Honorable William R. Kotapish
Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90GO1353R000200190003-1
 Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90G01353R000200190003-1
PROPOSED, AGENDA
NATIONAL DRUG POLICY BOARD
WEDNESDAY, JULY 27, 1988
3:00 P.M., ROOSEVELT ROOM
THE WHITE HOUSE
I. Opening Remarks (Vice Chairman)
DRAFT
II. Legislative Initiatives Update (Dr. Donald I. Macdonald
and Mr. Francis A. Keating II)
III. Public Health Service Proposal on Treatment
(Vice Chairman)
IV. Office of Workplace Initiatives (Vice Chairman)
V. Domestic Eradication Plan (Mr. Francis A. Keating and
Mr. John C. Lawn)
VI. DOD Role (Mr. Francis A. Keating)
VII. DOD Authorization Bill (Mr. Francis A. Keating)
Lead Role of DOD in Detection
Report to the Congress on Cost
VIII. President Commission on AIDS Report
(Dr. Donald I. Macdonald)
- Recommendations Concerning Drug Treatment
IX. Chemical Industry Issues (Mr. Francis A. Keating)
- Eli Lilly - "Spike"
Chevron - Paraquat
Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90G01353R000200190003-1
 Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90G01353R000200190003-1
f)KAFT
NATIONAL DRUG POLICY BOARD
Summary of Meeting
June 23, 1988
I. Introductory Remarks. The Chairman convened the meeting at
10:00 A.M. The summary of the May 27th meeting was approved
by the Board. Chairman Meese announced that there would be
no Administration drug bill, but instead the Policy Board
would submit a "checklist" of proposals to the Bi-Partisan
Legislative Task Force for consideration.
II. Legislative Update. The Chairman introduced an Issue Paper
containing priority items, identified by the Coordinating
Groups, that fall within the six policy goals, announced by
the President in 1986. Mr. Meese then turned the floor over
to the Coordinating Group Chairmen for discussion of their
Group's-proposals in the Issue Paper..
o Dr. Macdonald addressed items contained under
goals 1-3 and 6 that had been developed by the.
Demand side. Dr. Macdonald circulated two
handouts; one with proposed additions or
substitutions to the Issue Paper, the other
entitled "High-Risk Youth Initiative Elements."
o Frank Keating summarized the law enforcement
initiatives that comprise goals 4 and 5.
Ms. Wrobleski voiced State Department's opposition to
passport marking and advised the Chairman that all of the
International initiatives would require new funding. The
Board noted State's concern on the passport marking, however
the proposal was approved.
Chairman Meese asked for, and received, the Board's approval
of the Issue Paper and to recommend the President's
approval of these .measures . The Chairman asked the
Executive Director to modify the Issue Paper to reflect the
Board's amendments and to prepare briefing books based on
the Issue Paper for use by the Executive Legislative Task
Force negotiators.
III. Jack Lawn briefed the Board on the Domestic Cannabis
Suppression Strategy and advised that during week of July
11th, the Chairman would publicly announce the strategy
which has been named Operation Stop Crop. George Dunlop
asked that the strategy reflect increased focus on the
problem of marijuana cultivation on public lands, and
proposed specific language for this change. Chairman Meese
advised that the subject would be addressed in any of the
Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90G01353R000200190003-1
 ? V
Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90GO1353R000200190003-1
Administration's public statements concerning Operation
Stop Crop. Chairman Meese directed Mr. Keating to meet with
Messrs. Lawn and Dunlop to resolve any issues regarding
cross designation of Forest Service personnel to investigate'
marijuana cultivation cases.
IV. Marion Blakey, Director of Public Affairs for the White
House summarized the June 16th meeting of the, Public
Advocacy Working Group.
The meeting ended at 11:05 A.M.
Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90GO1353R000200190003-1
 Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90G01353R0002001.90003-1
4 Central Intelligence Agency Ly v v - -
-1 9 SEP 1989
Dr. Donald Ian Macdonald
Deputy Assistant to the President
for Drug Abuse Policy
The White House
Washington, D.C. 20500
Dear Dr. Macdonald:
Please be advised that the Central Intelligence Agency has a
fair and compassionate treatment policy for HIV-infected employees
and an information, education and personnel management policy
which is in full compliance with the Office of Personnel
Management's (OPM) and the Center for Disease Control's (CDC)
Guidelines for AIDS.
The Central Intelligence Agency requests an exemption from
further reporting requirements relative to our policy and program
on AIDS information, education and personnel management, due to
the covert status of many of our employees and the sensitive
nature of their occupations.
R. Huffstutler
Deputy Director
for
Administration
DA/0MS/EX0,
Distribution:
Orig - Adse
2 - DDA
1 - ER
1 - D/IBS Chrono
1 - D/MS File
(retyped 14 Sep 88)
STAT
STAT
Declassified in Part - Sanitized Copy Approved for Release 2012/11/08: CIA-RDP90G01353R000200190003-1